{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T11:47:07Z","timestamp":1782733627368,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"5010 Clinical Research Project of Sun Yat-sen University","award":["2018018"],"award-info":[{"award-number":["2018018"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural and Science Foundation of China","doi-asserted-by":"crossref","award":["81902627"],"award-info":[{"award-number":["81902627"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-23853-8","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T13:24:37Z","timestamp":1763472277000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["An assisted diagnostic and prognostic model for endometrial cancer using 36 serological markers and clinical variables from 562 patients"],"prefix":"10.1038","volume":"15","author":[{"given":"Fangying","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meilian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"23853_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"23853_CR2","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1056\/NEJMra1514010","volume":"383","author":"KH Lu","year":"2020","unstructured":"Lu, K. H. & Broaddus, R. R. Endometrial cancer. N. Engl. J. Med. 383, 2053\u20132064. https:\/\/doi.org\/10.1056\/NEJMra1514010 (2020).","journal-title":"N. Engl. J. Med."},{"key":"23853_CR3","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.2217\/fon.14.192","volume":"10","author":"MA Sheikh","year":"2014","unstructured":"Sheikh, M. A. et al. USA endometrial cancer projections to 2030: should we be concerned?. Futur. Oncol. (London, England) 10, 2561\u20132568. https:\/\/doi.org\/10.2217\/fon.14.192 (2014).","journal-title":"Futur. Oncol. (London, England)"},{"key":"23853_CR4","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/his.14609","volume":"80","author":"WG McCluggage","year":"2022","unstructured":"McCluggage, W. G., Singh, N. & Gilks, C. B. Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020). Histopathology 80, 762\u2013778. https:\/\/doi.org\/10.1111\/his.14609 (2022).","journal-title":"Histopathology"},{"key":"23853_CR5","doi-asserted-by":"publisher","first-page":"484","DOI":"10.5858\/arpa.2012-0709-RA","volume":"138","author":"RA Owings","year":"2014","unstructured":"Owings, R. A. & Quick, C. M. Endometrial intraepithelial neoplasia. Arch. Pathol. Lab. Med. 138, 484\u2013491. https:\/\/doi.org\/10.5858\/arpa.2012-0709-RA (2014).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"23853_CR6","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1097\/aog.0b013e31826bb121","volume":"120","author":"CL Trimble","year":"2012","unstructured":"Trimble, C. L. et al. Management of endometrial precancers. Obstet. Gynecol. 120, 1160\u20131175. https:\/\/doi.org\/10.1097\/aog.0b013e31826bb121 (2012).","journal-title":"Obstet. Gynecol."},{"key":"23853_CR7","doi-asserted-by":"publisher","unstructured":"Colombo, N. et al. ESMO-ESGO-ESTRO Consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Ann Oncol 27 16-41 https:\/\/doi.org\/10.1093\/annonc\/mdv484 (2016).","DOI":"10.1093\/annonc\/mdv484"},{"key":"23853_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092577","author":"S Marnitz","year":"2020","unstructured":"Marnitz, S. et al. A modern approach to endometrial carcinoma: will molecular classification improve precision medicine in the future?. Cancers https:\/\/doi.org\/10.3390\/cancers12092577 (2020).","journal-title":"Cancers"},{"key":"23853_CR9","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1067\/mob.2000.107335","volume":"182","author":"A Mariani","year":"2000","unstructured":"Mariani, A. et al. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?. Am. J. Obstet. Gynecol. 182, 1506\u20131519. https:\/\/doi.org\/10.1067\/mob.2000.107335 (2000).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"23853_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","volume":"31","author":"N Concin","year":"2021","unstructured":"Concin, N. et al. ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma. Int. J. Gynecol. Cancer 31, 12\u201339. https:\/\/doi.org\/10.1136\/ijgc-2020-002230 (2021).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"23853_CR11","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ygyno.2021.05.026","volume":"162","author":"S Imboden","year":"2021","unstructured":"Imboden, S. et al. Implementation of the 2021 molecular ESGO\/ESTRO\/ESP risk groups in endometrial cancer. Gynecol. Onco.l 162, 394\u2013400. https:\/\/doi.org\/10.1016\/j.ygyno.2021.05.026 (2021).","journal-title":"Gynecol. Onco.l"},{"key":"23853_CR12","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1007\/s12672-025-03191-x","volume":"16","author":"F Cheng","year":"2025","unstructured":"Cheng, F., Yang, L., Wen, Q., Xu, J. & Shao, F. Risk factors and prognostic analysis of endometrial cancer with para-aortic lymph node metastasis. Discover Oncol. 16, 1344. https:\/\/doi.org\/10.1007\/s12672-025-03191-x (2025).","journal-title":"Discover Oncol."},{"key":"23853_CR13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jpba.2014.12.017","volume":"113","author":"R Bujak","year":"2015","unstructured":"Bujak, R., Struck-Lewicka, W., Markuszewski, M. J. & Kaliszan, R. Metabolomics for laboratory diagnostics. J. Pharm. Biomed. Anal. 113, 108\u2013120. https:\/\/doi.org\/10.1016\/j.jpba.2014.12.017 (2015).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"23853_CR14","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1021\/acs.jproteome.7b00503","volume":"17","author":"J Troisi","year":"2018","unstructured":"Troisi, J. et al. Metabolomic signature of endometrial cancer. J. Proteome. Res. 17, 804\u2013812. https:\/\/doi.org\/10.1021\/acs.jproteome.7b00503 (2018).","journal-title":"J. Proteome. Res."},{"key":"23853_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ygyno.2013.10.036","volume":"132","author":"DJ Brennan","year":"2014","unstructured":"Brennan, D. J. et al. Serum HE4 as a prognostic marker in endometrial cancer\u2013a population based study. Gynecol. Oncol. 132, 159\u2013165. https:\/\/doi.org\/10.1016\/j.ygyno.2013.10.036 (2014).","journal-title":"Gynecol. Oncol."},{"key":"23853_CR16","first-page":"540","volume":"34","author":"M Bozkurt","year":"2013","unstructured":"Bozkurt, M., Yumru, A. E. & Aral, I. Evaluation of the importance of the serum levels of CA-125, CA15-3, CA-19-9, carcinoembryonic antigen and alpha fetoprotein for distinguishing benign and malignant adnexal masses and contribution of different test combinations to diagnostic accuracy. Eur. J. Gynaecol. Oncol. 34, 540\u2013544 (2013).","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"23853_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ygyno.2015.11.020","volume":"140","author":"P Kemik","year":"2016","unstructured":"Kemik, P. et al. Diagnostic and prognostic values of preoperative serum levels of YKL-40, HE-4 and DKK-3 in endometrial cancer. Gynecol. Oncol. 140, 64\u201369. https:\/\/doi.org\/10.1016\/j.ygyno.2015.11.020 (2016).","journal-title":"Gynecol. Oncol."},{"key":"23853_CR18","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1177\/1533034616666644","volume":"16","author":"J Bian","year":"2017","unstructured":"Bian, J., Sun, X., Li, B. & Ming, L. Clinical significance of serum HE4, CA125, CA724, and CA19-9 in patients with endometrial cancer. Technol. Cancer Res. Treat. 16, 435\u2013439. https:\/\/doi.org\/10.1177\/1533034616666644 (2017).","journal-title":"Technol. Cancer Res. Treat."},{"key":"23853_CR19","first-page":"59","volume":"2","author":"JA Cruz","year":"2007","unstructured":"Cruz, J. A. & Wishart, D. S. Applications of machine learning in cancer prediction and prognosis. Cancer Inf. 2, 59\u201377 (2007).","journal-title":"Cancer Inf."},{"key":"23853_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","volume":"497","author":"C Kandoth","year":"2013","unstructured":"Kandoth, C. et al. Integrated genomic characterization of endometrial carcinoma. Nature 497, 67\u201373. https:\/\/doi.org\/10.1038\/nature12113 (2013).","journal-title":"Nature"},{"key":"23853_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.895834","volume":"12","author":"W Lu","year":"2022","unstructured":"Lu, W. et al. A model to identify candidates for lymph node dissection among patients with high-risk endometrial endometrioid carcinoma according to mayo criteria. Front. Oncol. 12, 895834. https:\/\/doi.org\/10.3389\/fonc.2022.895834 (2022).","journal-title":"Front. Oncol."},{"key":"23853_CR22","doi-asserted-by":"publisher","DOI":"10.4293\/jsls.2020.00011","author":"A Giglio","year":"2020","unstructured":"Giglio, A. et al. Challenges to intraoperative evaluation of endometrial cancer. Jsls https:\/\/doi.org\/10.4293\/jsls.2020.00011 (2020).","journal-title":"Jsls"},{"key":"23853_CR23","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","volume":"387","author":"P Morice","year":"2016","unstructured":"Morice, P., Leary, A., Creutzberg, C., Abu-Rustum, N. & Darai, E. Endometrial cancer. The Lancet 387, 1094\u20131108. https:\/\/doi.org\/10.1016\/S0140-6736(15)00130-0 (2016).","journal-title":"The Lancet"},{"key":"23853_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/tog.12722","volume":"23","author":"ER Jones","year":"2021","unstructured":"Jones, E. R., O\u2019Flynn, H., Njoku, K. & Crosbie, E. J. Detecting endometrial cancer. Obstet. Gynaecol. 23, 103\u2013112. https:\/\/doi.org\/10.1111\/tog.12722 (2021).","journal-title":"Obstet. Gynaecol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23853-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23853-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23853-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T02:03:31Z","timestamp":1763517811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23853-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23853"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23853-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"22 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Fangying Chen, Meilian Chen, Ruyun Chen, Liwei Xiao and Jiaming Huang have nothing to disclose. Jiaming Huang reports grants: 5010 Clinical Research Project of Sun Yat-sen University (2,018,018), National Natural and Science Foundation of China (81,902,627 , personal fees and non-financial support outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40441"}}